Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
{{output}}
Background Combination therapy of gemcitabine with cisplatin (GC) is a standard first-line therapy for unresectable or recurrent biliary tract cancer (BTC). S-1 is often used as a second-line therapy in clinical practice, based on the results of some clinical ... ...
